Skip to main content
OpenTrials

Clinical trial condition

Glycogen Storage Disease Type II

Explore clinical trials studying Glycogen Storage Disease Type II. Study availability and eligibility vary by location and protocol.

105 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Glycogen Storage Disease Type II trial results

Completed

Alglucosidase Alfa Pompe Safety Sub-Registry

NCT01710813

Conditions
Anaphylaxis, Brain Diseases, Brain Diseases, Metabolic, +17 more
Locations
  • Investigational Site Number 840016 Phoenix, Arizona, United States
  • Investigational Site Number 840002 Durham, North Carolina, United States
  • Investigational Site Number 840004 Hershey, Pennsylvania, United States
  • Investigational Site Number 840014 Pittsburgh, Pennsylvania, United States
View all 18 locations
View Trial Details
Completed

Long-term Outcome in Late-onset Pompe Disease Treated Beyond 36 Months (STIG-Pompe-Study)

NCT02824068

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • Friedrich-Baur-Institute, Dep. of Neurology Klinikum der Universitaet Muenchen Munich, Germany Munich, Bavaria, Germany
  • 5. Department of Clinical and Experimental Medicine, Reference Center for Rare Neuromuscular Disorders, University of Messina, Italy Messina, Sicily, Italy
  • National Taiwan University Hospital Taipei Taipei, Taiwan
View Trial Details
Completed

Pompe Disease QMUS and EIM

NCT02742298

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details

Related conditions